What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
- 30 April 2005
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Rheumatology
- Vol. 19 (2), 263-276
- https://doi.org/10.1016/j.berh.2004.10.003
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- The role of flow cytometric ANCA detection in screening for acute pauci-immune crescentic glomerulonephritisNephrology Dialysis Transplantation, 2004
- Diagnostic predictive value of ANCA serologyKidney International, 1998
- Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa GroupRheumatology, 1996
- Specificity of cANCA for Wegener's granulomatosisAustralian and New Zealand Journal of Medicine, 1996
- Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosisQJM: An International Journal of Medicine, 1996
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosisArthritis & Rheumatism, 1990
- Anticytoplasmic Autoantibodies in the Diagnosis and Follow-Up of Wegener's GranulomatosisMayo Clinic Proceedings, 1989
- Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic GlomerulonephritisThe New England Journal of Medicine, 1988
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985